MD
Pediatrix Medical Group, Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+30/100
Last price
26.00
▼ 0.10 (0.38%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
26.05
Prev close
26.10
Day high
26.51
Day low
25.70
Volume
667.74K
Market cap
$2.11B
P/E (TTM)
12.50
52W range
15.70 – 27.94
Day trading desk
Gap from prior close
-0.19%
Prior close 26.10
VWAP
25.97
+0.13% from price
Relative volume
1.63×
Unusually busy
Session range
3.15%
25.70 – 26.51
Position in range
37%
Mid range
ATR (14D)
0.78
2.99% of price
Prior day high
26.46
PDH
Prior day low
25.59
PDL
Bid / ask spread
—
Quote not published
Session volume
1.27M
Avg 779.19K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.23%
-2.2%
1M
-3.81%
-5.0%
3M
-2.95%
-7.5%
6M
+19.60%
+1.4%
YTD
+21.55%
+7.3%
1Y
+48.57%
+32.2%
3Y
+104.56%
+22.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on MD open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+436.07K
Net buying
Buy transactions
23
472.10K shares
Sell transactions
1
36.03K shares
Net transactions
+24
Buys less sells
Sell : buy shares
0.1 : 1
Mixed
Insider-held shares
1.61M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 12, 26 | YOUNG SYLVIA JEAN Director |
STOCK | 472 | $12.51K | Direct |
| Aug 12, 26 | NEWMAN KURT DOUGLAS M.D. Director |
STOCK | 472 | $12.51K | Direct |
| Aug 12, 26 | SANSONE GUY P Director |
STOCK | 472 | $12.51K | Direct |
| Aug 12, 26 | LINYNSKY LAURA A Director |
STOCK | 472 | $12.51K | Direct |
| Aug 12, 26 | STARCHER JOHN M JR. Director |
STOCK | 472 | $12.51K | Direct |
| Aug 12, 26 | RUCKER MICHAEL A Director |
STOCK | 472 | $12.51K | Direct |
| Aug 12, 26 | WEIS SHIRLEY A Director |
STOCK | 472 | $12.51K | Direct |
| Aug 12, 26 | MCEACHIN THOMAS A Director |
STOCK | 472 | $12.51K | Direct |
| Jun 22, 26 | HADDOCK DAVID General Counsel |
STOCK | 20.04K | $0 | Direct |
| Jun 9, 26 | MOORE MARY ANN E General Counsel |
STOCK | 18.41K | $0 | Direct |
| Jun 2, 26 | ORDAN MARK S Chief Executive Officer |
STOCK | 224.37K | $0 | Direct |
| Jun 1, 26 | ROSSI KASANDRA H Chief Financial Officer |
STOCK | 31.80K | $0 | Direct |
| Jun 1, 26 | NEEB DON GREGORY Chief Investment Officer |
STOCK | 63.89K | $0 | Direct |
| May 13, 26 | WEIS SHIRLEY A Director |
SELL | 36.03K | $855.66K | Indirect |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
LINYNSKY LAURA A |
Director | 39.90K | Stock Award(Grant) |
MCEACHIN THOMAS A |
Director | 73.74K | Stock Award(Grant) |
MOORE MARY ANN E |
General Counsel | 189.89K | Stock Gift |
NEEB DON GREGORY |
Chief Investment Officer | 137.23K | Stock Award(Grant) |
ORDAN MARK S |
Chief Executive Officer | 410.88K | Stock Award(Grant) |
ROSSI KASANDRA H |
Chief Financial Officer | 101.40K | Stock Award(Grant) |
RUCKER MICHAEL A |
Director | 66.77K | Stock Award(Grant) |
SANSONE GUY P |
Director | 87.42K | Stock Award(Grant) |
STARCHER JOHN M JR. |
Director | 73.73K | Stock Award(Grant) |
YOUNG SYLVIA JEAN |
Director | 48.29K | Stock Award(Grant) |
Fundamentals
Market cap$2.11B
Enterprise value$2.28B
Revenue (TTM)$1.95B
Gross profit$511.77M
EBITDA$263.74M
Net income$174.81M
EPS (TTM)$2.08
Free cash flow$160.78M
Total cash$404.20M
Total debt$619.96M
Book value / share$11.11
Shares outstanding81.25M
Float77.99M
Short % of float8.30%
Dividend yield0.00%
Beta (5Y)0.61
Valuation & profitability ratios
Trailing P/E12.50
Forward P/E10.65
PEG ratio0.24
Price / sales—
Price / book2.34
EV / revenue1.17
EV / EBITDA8.64
Gross margin26.24%
Operating margin13.41%
Profit margin8.96%
Return on equity20.39%
Return on assets7.11%
Debt / equity70.37
Current ratio1.32
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.91B | $2.01B | $1.99B | $1.97B | -4.9% |
| Operating revenue | $1.90B | $2.01B | $1.99B | $1.95B | -5.4% |
| Cost of revenue | $1.42B | $1.56B | $1.57B | $1.50B | -8.9% |
| Gross profit | $493.70M | $454.34M | $421.56M | $467.03M | +8.7% |
| Selling, general & admin | $240.79M | $238.44M | $227.54M | $231.40M | +1.0% |
| Total operating expense | $262.62M | $270.66M | $263.71M | $267.03M | -3.0% |
| Operating income | $231.09M | $183.68M | $157.85M | $200.00M | +25.8% |
| Net interest income | -$35.97M | -$40.74M | -$42.08M | -$39.70M | +11.7% |
| Pre-tax income | $216.43M | -$101.34M | -$48.36M | $81.37M | +313.6% |
| Tax provision | $51.04M | -$2.27M | $12.05M | $18.81M | +2,346.7% |
| Net income | $165.39M | -$99.07M | -$60.41M | $66.33M | +266.9% |
| Net income to common | $165.39M | -$99.07M | -$60.41M | $66.33M | +266.9% |
| Basic EPS | 1.99 | -1.15 | -0.72 | 0.80 | +272.8% |
| Diluted EPS | 1.94 | -1.19 | -0.73 | 0.79 | +263.0% |
| EBIT | $252.40M | -$60.60M | -$6.28M | $121.06M | +516.5% |
| EBITDA | $274.22M | -$28.37M | $29.89M | $156.70M | +1,066.5% |
| Basic shares | 82.98M | 85.87M | 84.02M | 82.95M | -3.4% |
| Diluted shares | 85.27M | 85.87M | 84.02M | 84.12M | -0.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $375.24M | $229.94M | $73.26M | $9.82M | +63.2% |
| Cash & short-term investments | $499.72M | $348.51M | $177.74M | $103.06M | +43.4% |
| Accounts receivable | $229.66M | $259.99M | $272.31M | $296.79M | -11.7% |
| Total current assets | $763.51M | $639.61M | $483.45M | $427.99M | +19.4% |
| Property, plant & equipment | $73.51M | $78.44M | $145.93M | $140.21M | -6.3% |
| Goodwill & intangibles | $1.28B | $1.25B | $1.41B | $1.55B | +1.9% |
| Total assets | $2.25B | $2.15B | $2.22B | $2.35B | +4.4% |
| Total current liabilities | $458.91M | $434.11M | $388.95M | $426.98M | +5.7% |
| Current debt | $25.00M | $18.75M | $12.50M | $12.50M | +33.3% |
| Long-term debt | $568.95M | $593.57M | $611.59M | $627.65M | -4.1% |
| Total debt | $634.62M | $662.31M | $701.65M | $717.08M | -4.2% |
| Total liabilities | $1.38B | $1.39B | $1.37B | $1.46B | -0.5% |
| Retained earnings | -$83.15M | -$248.54M | -$149.47M | -$89.06M | +66.5% |
| Shareholder equity | $865.85M | $764.94M | $849.06M | $891.63M | +13.2% |
| Working capital | $304.60M | $205.50M | $94.51M | $1.01M | +48.2% |
| Net tangible assets | -$411.74M | -$489.26M | -$556.35M | -$658.95M | +15.8% |
| Shares issued | 82.98M | 85.87M | 84.02M | 82.95M | -3.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $165.39M | -$99.07M | -$60.41M | $62.57M | +266.9% |
| Depreciation & amortisation | $21.83M | $32.23M | $36.17M | $35.64M | -32.3% |
| Stock-based compensation | $18.05M | $11.87M | $12.32M | $16.13M | +52.0% |
| Change in working capital | $41.83M | $88.24M | -$11.63M | $31.83M | -52.6% |
| Operating cash flow | $271.09M | $206.57M | $137.32M | $166.94M | +31.2% |
| Capital expenditure | -$18.46M | -$22.02M | -$33.33M | -$29.71M | +16.2% |
| Investing cash flow | -$18.30M | -$35.41M | -$48.18M | -$56.95M | +48.3% |
| Share buybacks | -$86.68M | -$1.70M | -$919.00K | -$88.51M | -4,990.0% |
| Financing cash flow | -$107.49M | -$14.48M | -$25.71M | -$487.55M | -642.1% |
| Free cash flow | $252.63M | $184.55M | $104.00M | $137.23M | +36.9% |
| End cash position | $375.24M | $229.94M | $73.26M | $9.82M | +63.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $487.78M | $476.20M | $493.77M | $492.88M | $468.84M | +2.4% |
| Operating revenue | $487.00M | $475.27M | $491.54M | $489.91M | $465.63M | +2.5% |
| Cost of revenue | $355.31M | $363.23M | $367.79M | $352.53M | $344.12M | -2.2% |
| Gross profit | $132.47M | $112.96M | $125.98M | $140.35M | $124.73M | +17.3% |
| Selling, general & admin | $61.29M | $60.27M | $65.68M | $60.79M | $55.71M | +1.7% |
| Total operating expense | $67.07M | $66.39M | $71.31M | $66.34M | $61.03M | +1.0% |
| Operating income | $65.40M | $46.58M | $54.67M | $74.00M | $63.70M | +40.4% |
| Net interest income | -$8.17M | -$8.27M | -$8.74M | -$8.94M | -$9.13M | +1.1% |
| Pre-tax income | $54.00M | $38.84M | $45.59M | $87.78M | $54.97M | +39.0% |
| Tax provision | $14.16M | $9.27M | $11.91M | $16.07M | $15.71M | +52.7% |
| Net income | $39.84M | $29.57M | $33.68M | $71.71M | $39.26M | +34.7% |
| Net income to common | $39.84M | $29.57M | $33.68M | $71.71M | $39.26M | +34.7% |
| Basic EPS | 0.50 | 0.36 | 0.41 | 0.85 | 0.45 | +38.7% |
| Diluted EPS | 0.49 | 0.36 | 0.40 | 0.84 | 0.45 | +36.1% |
| EBIT | $62.17M | $47.11M | $54.34M | $96.72M | $64.10M | +32.0% |
| EBITDA | $67.95M | $53.23M | $59.97M | $102.27M | $69.41M | +27.7% |
| Basic shares | 79.44M | 82.06M | 82.98M | 84.61M | 86.85M | -3.2% |
| Diluted shares | 81.41M | 83.08M | 84.42M | 85.61M | 86.85M | -2.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $288.88M | $205.78M | $375.24M | $340.06M | $224.73M | +40.4% |
| Cash & short-term investments | $404.20M | $328.97M | $499.72M | $463.10M | $348.33M | +22.9% |
| Accounts receivable | $227.60M | $224.80M | $229.66M | $231.12M | $238.99M | +1.2% |
| Total current assets | $660.14M | $587.03M | $763.51M | $717.20M | $613.05M | +12.5% |
| Property, plant & equipment | $73.89M | $77.97M | $73.51M | $74.34M | $77.63M | -5.2% |
| Goodwill & intangibles | $1.28B | $1.28B | $1.28B | $1.27B | $1.25B | -0.1% |
| Total assets | $2.13B | $2.07B | $2.25B | $2.20B | $2.10B | +2.9% |
| Total current liabilities | $501.58M | $442.64M | $458.91M | $392.55M | $341.04M | +13.3% |
| Current debt | $186.18M | $192.42M | $25.00M | $25.34M | $23.68M | -3.2% |
| Long-term debt | $398.06M | $398.35M | $568.95M | $577.17M | $583.86M | -0.1% |
| Total debt | $619.96M | $629.72M | $634.62M | $642.27M | $649.56M | -1.5% |
| Total liabilities | $1.25B | $1.19B | $1.38B | $1.31B | $1.27B | +4.8% |
| Retained earnings | -$13.74M | -$53.58M | -$83.15M | -$116.83M | -$188.54M | +74.4% |
| Shareholder equity | $880.98M | $878.58M | $865.85M | $890.67M | $833.75M | +0.3% |
| Working capital | $158.56M | $144.40M | $304.60M | $324.65M | $272.01M | +9.8% |
| Net tangible assets | -$401.79M | -$405.61M | -$411.74M | -$379.56M | -$418.15M | +0.9% |
| Shares issued | 81.22M | 82.06M | 82.98M | 85.83M | 86.85M | -1.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $39.84M | $29.57M | $33.68M | $71.71M | $39.26M | +34.7% |
| Depreciation & amortisation | $5.78M | $6.12M | $5.63M | $5.55M | $5.31M | -5.5% |
| Stock-based compensation | $5.08M | $4.66M | $5.34M | $5.15M | $3.91M | +8.9% |
| Change in working capital | $64.78M | -$177.63M | $46.02M | $67.44M | $78.06M | +136.5% |
| Operating cash flow | $125.32M | -$129.85M | $114.10M | $137.28M | $137.17M | +196.5% |
| Capital expenditure | -$1.38M | -$6.25M | -$5.29M | -$5.34M | -$4.51M | +77.9% |
| Investing cash flow | $6.02M | -$11.98M | -$10.28M | $6.60M | -$7.15M | +150.2% |
| Share buybacks | -$42.74M | -$21.45M | -$64.04M | -$20.87M | -$209.00K | -99.3% |
| Financing cash flow | -$48.24M | -$27.64M | -$68.64M | -$28.56M | -$4.26M | -74.6% |
| Free cash flow | $123.94M | -$136.09M | $108.81M | $131.95M | $132.65M | +191.1% |
| End cash position | $288.88M | $205.78M | $375.24M | $340.06M | $224.73M | +40.4% |
Options analytics
Put / call volume
7.75
Put-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
15.00
-42.3% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
4
Contracts, this expiry
Put volume
31
Contracts, this expiry
Heaviest call OI
25.00
0 contracts
Heaviest put OI
15.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.59 | 0.63 | +6.6% |
| Mar 2026 | 0.38 | 0.44 | +16.0% |
| Dec 2025 | 0.54 | 0.50 | -7.1% |
| Sep 2025 | 0.47 | 0.67 | +43.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.65 | 7 | $498.18M | +1.1% |
| Next quarter | 0.63 | 7 | $499.14M | +1.1% |
| Current year | 2.35 | 7 | $1.96B | +2.5% |
| Next year | 2.44 | 6 | $2.01B | +2.4% |
Analyst targets & ownership
Mean target$26.33
High target$28.00
Low target$21.00
Implied upside1.28%
Analyst count6
ConsensusNONE
Strong buy / Buy0 / 1
Hold6
Sell / Strong sell0 / 0
Held by insiders2.03%
Held by institutions107.45%
Institutions holding423
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
25.94
+0.24% from price
SMA 20
26.16
-0.62% from price
SMA 50
26.37
-1.39% from price
SMA 100
25.27
+2.87% from price
SMA 200
23.33
+11.45% from price
EMA 12
26.02
-0.08% from price
EMA 26
26.15
-0.59% from price
EMA 50
26.05
-0.17% from price
RSI (14)
47.8
Neutral
MACD (12,26,9)
-0.13
Hist -0.01
ATR (14)
0.78
2.99% of price
Realised vol 30D
19.6%
Annualised
Bollinger upper
27.05
20, 2σ
Bollinger lower
25.28
20, 2σ
50 / 200 cross
Golden
26.37 vs 23.33
Trend bias
Above 200
+11.45%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.44
Less volatile than market
Correlation to SPY
0.14
Largely independent
Realised vol 30D
19.6%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-23.7%
Peak to trough
Max drawdown 5Y
-76.4%
Peak to trough
ATR 14
0.78
2.99% of price
Beta (reported)
0.61
5Y monthly, from filing
Short interest
Shares short
4.73M
Prior 4.94M
Change vs prior
-4.3%
Shorts covering
% of float
8.30%
Normal
% of shares out
5.82%
Against total outstanding
Days to cover
6.5
Crowded exit
Float
77.99M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 19, 26 | Jefferies | DOWNGRADE | Buy | Hold |
| Aug 6, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Jul 14, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| May 12, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Apr 13, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| Feb 24, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Feb 20, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| Nov 10, 25 | Truist Securities | MAINTAINED | Hold | Hold |
| Nov 5, 25 | UBS | MAINTAINED | Neutral | Neutral |
| Sep 5, 25 | Leerink Partners | MAINTAINED | Market Perform | Market Perform |
| Aug 14, 25 | UBS | MAINTAINED | Neutral | Neutral |
| May 12, 25 | UBS | MAINTAINED | Neutral | Neutral |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split2:1
Split dateDec 20, 2013
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-04
Corporate Changes & Voting Matters
8-K · 2026-07-24
Corporate Changes & Voting Matters
8-K · 2026-07-15
Offering Registrations
S-8 · 2026-05-21
Corporate Changes & Voting Matters
8-K · 2026-05-07
Corporate Changes & Voting Matters
8-K · 2026-05-05
Proxy Statements
DEFA14A · 2026-04-17
Proxy Statements
DEF 14A · 2026-03-27
Headlines
3 Unpopular Stocks with Questionable Fundamentals
StockStory · 20h ago
3 Healthcare Stocks That Concern Us
StockStory · 7d ago
Can Pediatrix Sustain Growth Despite Lower Patient Volumes?
Zacks · 15d ago
Pediatrix Medical Group (MD) Could Be 2% Below Fair Value Following Its Pullback
Simply Wall St. · 16d ago
1 Safe-and-Steady Stock to Research Further and 2 We Turn Down
StockStory · 19d ago
Pediatrix (MD) Grows Earnings Even As Patient Volumes Keep Falling
Insider Monkey · 21d ago
3 Stocks Under $50 with Questionable Fundamentals
StockStory · 22d ago
1 Cash-Producing Stock to Research Further and 2 Facing Challenges
StockStory · 27d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.